RTI-HS Leads Consortium Working on EMA-funded Project to Aid Real-World Data Use

Share on: 

The European Medicines Agency (EMA) MINERVA project (Metadata for data discoverability and study replicability in observational studies) is launched

Ensuring patients can trust the safety and effectiveness of their medicines is at the center of EMA’s authority. In addition to data from clinical trials, EMA seeks to employ information from observational studies designed to understand the use of medications in clinical practice, provide critical insights, and help inform regulatory decisions.

Visual representation of metadata and real-world evidence

EMA has recently launched the MINERVA project aimed at “strengthening the use of real-world data in medicines development.” RTI Health Solutions (RTI-HS) researchers will coordinate the project and lead several tasks in a collaborative Consortium with 15 research partners in Europe.

“This project will represent a coordinated effort by multiple research partners to initiate the creation of a valuable tool to aid study investigators and regulators,” explained Susana Perez-Gutthann, Vice President, Global Head of Epidemiology at RTI-HS. The Consortium will develop a sustainable process to define metadata and a proof-of-concept tool to collect and visualize the metadata from selected real-world data sources. The Consortium will then develop a good-practice guide with the description of the metadata and recommendations on their use for identifying and assessing the suitability of data sources for a specific study and contributing to assessing the evidentiary value of study results.

The following institutions participate in this collaborative research effort:

  • Aarhus University Department of Clinical Epidemiology, Denmark
  • Regional Health Agency (ARS) Toscana, Italy
  • Foundation for the Promotion of Health and Biomedical Research of the Valencia Region (FISABIO), Spain
  • Aragon Health Sciences Institute (IACS), Spain
  • Karolinska Institutet Centre of Pharmacoepidemiology (KI CPE), Sweden
  • Leibniz-Institute for Prevention Research and Epidemiology (BIPS), Germany
  • London School of Health and Tropical Medicine (LSHTM), United Kingdom
  • PHARMO Institute, Netherlands
  • RTI Health Solutions, Spain
  • Spanish Agency of Medicines and Medical Devices (AEMPS), Spain
  • Spanish Working Group on Chron’s Disease and Ulcerative Colitis (GETECCU), Spain
  • University of Bordeaux, France
  • University of Ljubljana Faculty of Pharmacy (UL FFA), Slovenia
  • University Medical Centre Groningen (UMCG), Netherlands
  • University Medical Centre Utrecht (UMCU), Netherlands
  • Utrecht University (UU), Netherlands


Staff Members